We're funding Dr Alison Tree, an oncologist at the Royal Marsden, to trial a new kind of radiotherapy that keeps hormone therapy working for longer in men with advanced disease. She tells us about the cutting-edge technology behind the potential new treatment and the big hopes she has for it.
BLOG: Our research comms officer, Ruby Kell, explains how a promising new test we're funding could help identify men whose radiotherapy is likely to fail, then target them with a commonly-used drug that will stop the treatment from being thwarted.
More news from the National Cancer Research Institute (NCRI) Cancer Conference this week comes from researchers at the Institute of Cancer Research (ICR) in London. They’ve carried out a large-scale analysis of patient data from another trial to predict which men are most likely to experience unpleasant side effects after radiotherapy.
In this guest blog Dr Chris Armstrong – Marcher, Mo grower and ambitious researcher – explains what he hopes to achieve with the Travelling Prize Fellowship we’ve just awarded him and how this critical leg up the academic research ladder will benefit men with prostate cancer.
A type of radiotherapy that shapes radiation beams to tumors has grabbed headlines today. But more in-depth trials, already underway, are needed to give a clearer picture of the benefit for men.
BLOG: We're only 12 months into our ten-year strategy to tame prostate cancer, but that doesn't mean we haven't already made exciting progress. Our resident expert, Dr Ian Le Guillou, gives us his top ten biggest research breakthroughs (in no particular order) from 2016.
Results from a 14-year radiotherapy study published today show that men can get the same benefit from a lower dose of radiotherapy with 17 fewer hospital visits.
BLOG: Is radiotherapy a safe option for men with prostate cancer? Sophie Lutter delves behind the headlines to see what the science say
First trial of shorter, more convenient radiotherapy treatment for men with prostate cancer could reduce the number of exhausting visits to hospital.
BLOG: Following the announcement of our five new PhD scientists last week, Sophie Lutter finds out how one doctorate researcher used their grant from Prostate Cancer UK to make new advances in overcoming radiotherapy resistance in cancer cells.